LeonaBio reported net income of -32.95M for the quarter ended Mar 2026. This income statement covers 27 quarters of results from Sep 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||||||||||||||||||||
| Research & Development (Quarter)R&D (Qtr) | 12.02M | 10.71M | 12.62M | 14.46M | 14.80M | 16.96M | 15.24M | 21.29M | 21.61M | 27.20M | 23.68M | 21.24M | 22.15M | 17.92M | 9.37M | 4.30M | 3.66M | 2.83M | 6.71M | 11.26M | |||||||
| Selling, General & Administrative (Quarter)SG&A (Qtr) | 4.61M | 7.12M | 6.16M | 8.93M | 8.77M | 7.17M | 7.69M | 8.48M | 10.03M | 7.84M | 6.96M | 6.45M | 5.87M | 7.57M | 6.20M | 5.23M | 3.63M | 4.05M | 3.77M | 6.88M | |||||||
| Restructuring Costs (Quarter)Restructuring (Qtr) | 10.00M | 4.13M | |||||||||||||||||||||||||
| Other Operating Expenses (Quarter)Other Opex (Qtr) | 1.60M | -24.77M | -24.58M | 75.79M | -7.66M | -5.45M | 86.42M | -0.93M | |||||||||||||||||||
| Operating Expenses (Quarter)Opex (Qtr) | 16.64M | 17.83M | 18.78M | 23.39M | 23.57M | 24.13M | 32.93M | 29.77M | 31.64M | 35.04M | 29.01M | 2.92M | 3.45M | 29.62M | 91.36M | 1.88M | 1.84M | 6.87M | 96.89M | 17.21M | |||||||
| Operating Income (Quarter)Op. Inc (Qtr) | -16.64M | -17.83M | -18.78M | -23.39M | -23.57M | -24.13M | -32.93M | -29.77M | -31.64M | -35.04M | -29.01M | -27.69M | -28.03M | -29.62M | -15.57M | -9.54M | -7.29M | -6.87M | -78.56M | -17.21M | |||||||
| EBIT (Quarter)EBIT (Qtr) | -16.64M | -17.83M | -18.78M | -23.39M | -23.57M | -24.13M | -32.93M | -29.77M | -31.64M | -35.04M | -29.01M | -27.69M | -28.03M | -29.62M | -15.57M | -9.54M | -7.29M | -6.87M | -78.56M | -17.21M | |||||||
| Non-operating items | |||||||||||||||||||||||||||
| Other Non Operating Income (Quarter)Other Non Op Inc. (Qtr) | 0.07M | 0.07M | 0.10M | 0.17M | 0.49M | 0.98M | 1.56M | 1.79M | 2.04M | 2.07M | 1.73M | 1.35M | 1.17M | 0.88M | 0.56M | 0.39M | 0.33M | 0.26M | 0.26M | 0.59M | |||||||
| Net income details | |||||||||||||||||||||||||||
| EBT (Quarter)EBT (Qtr) | -24.34M | -23.83M | -18.78M | -33.52M | -24.36M | -26.54M | -33.32M | -31.95M | -33.70M | -36.99M | -29.40M | -29.40M | -28.68M | -31.09M | -107.52M | -10.76M | -8.40M | -7.86M | -80.59M | -21.11M | |||||||
| Profit After Tax (Quarter)PAT (Qtr) | -13.97M | -15.71M | -16.76M | -20.98M | -24.34M | -20.19M | -30.14M | -27.82M | -29.60M | -32.97M | -25.68M | -26.34M | -26.86M | -28.70M | -14.65M | -9.15M | -6.97M | -6.61M | -82.89M | -32.95M | |||||||
| Income from Continuing Operations (Quarter)Income (Continuing) (Qtr) | -24.34M | -23.83M | -18.78M | -33.52M | -24.36M | -26.54M | -33.32M | -31.95M | -33.70M | -36.99M | -29.40M | -29.40M | -28.68M | -31.09M | -107.52M | -10.76M | -8.40M | -7.86M | -80.59M | -21.11M | |||||||
| Consolidated Net Income (Quarter)Consol Net Inc. (Qtr) | -24.34M | -23.83M | -18.78M | -33.52M | -24.36M | -26.54M | -33.32M | -31.95M | -33.70M | -36.99M | -29.40M | -29.40M | -28.68M | -31.09M | -107.52M | -10.76M | -8.40M | -7.86M | -80.59M | -21.11M | |||||||
| Income towards Parent Company (Quarter)Parent Net Inc (Qtr) | -24.34M | -23.83M | -18.78M | -33.52M | -24.36M | -26.54M | -33.32M | -31.95M | -33.70M | -36.99M | -29.40M | -29.40M | -28.68M | -31.09M | -107.52M | -10.76M | -8.40M | -7.86M | -80.59M | -21.11M | |||||||
| Net Income towards Common Stockholders (Quarter)Net Income (Qtr) | -24.34M | -23.83M | -18.78M | -33.52M | -24.36M | -26.54M | -33.32M | -31.95M | -33.70M | -36.99M | -29.40M | -29.40M | -28.68M | -31.09M | -107.52M | -10.76M | -8.40M | -7.86M | -80.59M | -21.11M | |||||||
| Additional items | |||||||||||||||||||||||||||
| EPS (Basic) (Quarter)EPS (Basic) (Qtr) | -6.54 | -6.39 | -5.09 | -8.92 | -6.47 | -7.02 | -8.83 | -8.42 | -8.87 | -9.72 | -7.73 | -7.67 | -7.47 | -8.07 | -27.94 | -2.76 | -2.15 | -1.99 | -18.85 | -1.11 | |||||||
| EPS (Diluted) (Quarter)EPS (Diluted) (Qtr) | -6.39 | -5.09 | -8.92 | -6.47 | -7.02 | -8.83 | -8.42 | -8.87 | -9.72 | -7.73 | -7.67 | -7.47 | -8.07 | -27.94 | -2.76 | -2.15 | -1.99 | -18.85 | -1.11 | ||||||||
| Shares Outstanding (Quarter)Shares Outstanding (Qtr) | 3.72M | 3.73M | 3.69M | 3.76M | 3.77M | 3.78M | 3.77M | 3.79M | 3.80M | 3.81M | 3.80M | 3.83M | 3.84M | 3.85M | 3.85M | 3.90M | 3.91M | 3.94M | 4.28M | 19.03M | |||||||
| Shares Outstanding (Diluted) (Quarter)Shares Outstanding (Dil.) (Qtr) | 3.73M | 3.69M | 3.76M | 3.77M | 3.78M | 3.77M | 3.79M | 3.80M | 3.81M | 3.80M | 3.83M | 3.84M | 3.85M | 3.85M | 3.90M | 3.91M | 3.94M | 4.28M | 19.03M | ||||||||
| Shares Outstanding (Entity) (Quarter)Shares Outstanding (Entity.) (Qtr) | 3.73M | 3.74M | 3.74M | 3.76M | 3.78M | 3.78M | 3.79M | 3.80M | 3.81M | 3.81M | 3.82M | 3.83M | 3.84M | 3.87M | 3.90M | 3.90M | 3.94M | 3.94M | 4.28M | 19.03M | |||||||
| EBITDA (Quarter)EBITDA (Qtr) | -16.64M | -17.83M | -18.78M | -23.39M | -23.57M | -24.13M | -32.93M | -29.77M | -31.64M | -35.04M | -29.01M | -27.69M | -28.03M | -29.62M | -15.57M | -9.54M | -7.29M | -6.87M | -78.56M | -17.21M | |||||||
| Interest Expenses (Quarter)Int Expense (Qtr) | 7.70M | 6.00M | -0.00M | 10.14M | 0.79M | 2.41M | 0.40M | 2.18M | 2.06M | 1.95M | 0.39M | 1.71M | 0.66M | 1.47M | 91.95M | 1.23M | 1.10M | 0.98M | 2.03M | 3.89M |